Liang Ma
6Patents
3h-index
41Co-inventors
57Inventor score
Filing activity: Aug 4, 1999 → Mar 15, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7326792B2 | Heterocyclic compounds as P2X7 ion channel blockers | Chemistry; Metallurgy | 25 | Expired |
| US6492553B1 | Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds | Chemistry; Metallurgy | 19 | Expired |
| US7741493B2 | Heterocyclic compounds as P2X7 ion channel blockers | Chemistry; Metallurgy | 3 | Active |
| US8202863B2 | Pyrimidine amide compounds as PGDS inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11274108B2 | Colony stimulating factor-1 receptor (CSF-1R) inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11591299B1 | Prodrug compound of levosimendan, preparation method and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.